Dupilumab Survival Compared to Upadacitinib, Tralokinumab in Atopic Dermatitis
These data suggest that dupilumab’s drug survival rate at 12 and 24 months is greater than that of upadacitinib and tralokinumab among patients with atopic dermatitis.
These data suggest that dupilumab’s drug survival rate at 12 and 24 months is greater than that of upadacitinib and tralokinumab among patients with atopic dermatitis.
Here’s why we find aortic valve repair to be a durable and effective option for treating many patients with aortic regurgitation.
Hear from a Mayo Clinic sport cardiologist about playing it safe: Tips to stay in the heart safety zone during the big game.
Explore this post and more from the GenX community
Do your hands feel dry and irritated after washing? Here are some ways to make hand washing less harsh on your skin.
U.S. businesses that sold goods and services to USAID are in limbo, including American farms dealing in rice, wheat and soybeans.
Using graphics to illustrate the scope of U.S. foreign aid spending and analyzing how the Trump administration’s sweeping cuts could play out across the world.
Washington has funded roughly a third of the aid sent to the enclave since the war began. With most agency workers set to be put…
The stop-work order on U.S.A.I.D.-funded research has left thousands of people with experimental drugs and devices in their bodies, with no access to monitoring or…
A former Republican director of USAID says the agency is critical to U.S. interests and can’t be abolished or folded into the State Department.
Patients and health care advocates said the abrupt decision to halt U.S. funding for a lifesaving H.I.V. program led to widespread confusion. The backtracking didn’t…